LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 30338

Search options

  1. Article: Heterostructured g-CN/TiO

    Tatykayev, Batukhan / Chouchene, Bilel / Balan, Lavinia / Gries, Thomas / Medjahdi, Ghouti / Girot, Emilien / Uralbekov, Bolat / Schneider, Raphaël

    Nanomaterials (Basel, Switzerland)

    2020  Volume 10, Issue 7

    Abstract: Photocatalysts composed of graphitic carbon nitride (g-CN) and TiO ...

    Abstract Photocatalysts composed of graphitic carbon nitride (g-CN) and TiO
    Language English
    Publishing date 2020-07-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662255-5
    ISSN 2079-4991
    ISSN 2079-4991
    DOI 10.3390/nano10071387
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Selective optogenetic control of G

    Wagdi, Ahmed / Malan, Daniela / Sathyanarayanan, Udhayabhaskar / Beauchamp, Janosch S / Vogt, Markus / Zipf, David / Beiert, Thomas / Mansuroglu, Berivan / Dusend, Vanessa / Meininghaus, Mark / Schneider, Linn / Kalthof, Bernd / Wiegert, J Simon / König, Gabriele M / Kostenis, Evi / Patejdl, Robert / Sasse, Philipp / Bruegmann, Tobias

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 1765

    Abstract: G ...

    Abstract G
    MeSH term(s) Animals ; Humans ; Light ; Mammals ; Optogenetics ; Signal Transduction/physiology ; TRPC6 Cation Channel
    Chemical Substances TRPC6 Cation Channel
    Language English
    Publishing date 2022-04-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-29265-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: German Cardiac Arrest Registry: rationale and design of G-CAR.

    Pöss, Janine / Sinning, Christoph / Schreiner, Isabelle / Apfelbacher, Christian / Drewitz, Karl-Philipp / Hösler, Nadine / Schneider, Steffen / Pieske, Burkert / Böttiger, Bernd W / Ewen, Sebastian / Wienbergen, Harm / Kelm, Malte / Bock, Daniel / Graf, Tobias / Adler, Christoph / Dutzmann, Jochen / Knie, Wulf / Orban, Martin / Zeymer, Uwe /
    Michels, Guido / Thiele, Holger

    Clinical research in cardiology : official journal of the German Cardiac Society

    2022  Volume 112, Issue 4, Page(s) 455–463

    Abstract: ... warranted.: Study design: The German Cardiac Arrest Registry (G-CAR) is an observational, prospective ... Parallel to and after the pilot phase, scaling up of G-CAR to a national level is envisaged.: Conclusion ... G-CAR is the first national registry including a long-term follow-up for adult OHCA patients ...

    Abstract Background: In Germany, 70,000-100,000 persons per year suffer from out-of-hospital cardiac arrest (OHCA). Despite medical progress, survival rates with good neurological outcome remain low. For many important clinical issues, no or only insufficient evidence from randomised trials is available. Therefore, a systemic and standardised acquisition of the treatment course and of the outcome of OHCA patients is warranted.
    Study design: The German Cardiac Arrest Registry (G-CAR) is an observational, prospective, multicentre registry. It will determine the characteristics, initial treatment strategies, invasive procedures, revascularisation therapies and the use of mechanical circulatory support devices with a focus on extracorporeal cardiopulmonary resuscitation. A special feature is the prospective 12-month follow-up evaluating mortality, neurological outcomes and several patient-reported outcomes in the psychosocial domain (health-related quality of life, cognitive impairment, depression/anxiety, post-traumatic stress disorder and social reintegration). In a pilot phase of 24 months, 15 centres will include approximately 400 consecutive OHCA patients ≥ 18 years. Parallel to and after the pilot phase, scaling up of G-CAR to a national level is envisaged.
    Conclusion: G-CAR is the first national registry including a long-term follow-up for adult OHCA patients. Primary aim is a better understanding of the determinants of acute and long-term outcomes with the perspective of an optimised treatment.
    Trial registry: NCT05142124. German Cardiac Arrest Registry (G-CAR).
    MeSH term(s) Adult ; Humans ; Prospective Studies ; Treatment Outcome ; Quality of Life ; Extracorporeal Membrane Oxygenation/methods ; Cardiopulmonary Resuscitation/methods ; Out-of-Hospital Cardiac Arrest/therapy ; Registries
    Language English
    Publishing date 2022-06-21
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2213295-8
    ISSN 1861-0692 ; 1861-0684
    ISSN (online) 1861-0692
    ISSN 1861-0684
    DOI 10.1007/s00392-022-02044-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1.

    Seeling, Michaela / Pöhnl, Matthias / Kara, Sibel / Horstmann, Nathalie / Riemer, Carolina / Wöhner, Miriam / Liang, Chunguang / Brückner, Christin / Eiring, Patrick / Werner, Anja / Biburger, Markus / Altmann, Leon / Schneider, Martin / Amon, Lukas / Lehmann, Christian H K / Lee, Sooyeon / Kunz, Meik / Dudziak, Diana / Schett, Georg /
    Bäuerle, Tobias / Lux, Anja / Tuckermann, Jan / Vögtle, Timo / Nieswandt, Bernhardt / Sauer, Markus / Böckmann, Rainer A / Nimmerjahn, Falk

    Immunity

    2023  Volume 56, Issue 5, Page(s) 1046–1063.e7

    Abstract: Immunoglobulin G (IgG) antibodies are major drivers of inflammation during infectious and ...

    Abstract Immunoglobulin G (IgG) antibodies are major drivers of inflammation during infectious and autoimmune diseases. In pooled serum IgG (IVIg), however, antibodies have a potent immunomodulatory and anti-inflammatory activity, but how this is mediated is unclear. We studied IgG-dependent initiation of resolution of inflammation in cytokine- and autoantibody-driven models of rheumatoid arthritis and found IVIg sialylation inhibited joint inflammation, whereas inhibition of osteoclastogenesis was sialic acid independent. Instead, IVIg-dependent inhibition of osteoclastogenesis was abrogated in mice lacking receptors Dectin-1 or FcγRIIb. Atomistic molecular dynamics simulations and super-resolution microscopy revealed that Dectin-1 promoted FcγRIIb membrane conformations that allowed productive IgG binding and enhanced interactions with mouse and human IgG subclasses. IVIg reprogrammed monocytes via FcγRIIb-dependent signaling that required Dectin-1. Our data identify a pathogen-independent function of Dectin-1 as a co-inhibitory checkpoint for IgG-dependent inhibition of mouse and human osteoclastogenesis. These findings may have implications for therapeutic targeting of autoantibody and cytokine-driven inflammation.
    MeSH term(s) Animals ; Humans ; Mice ; Arthritis, Rheumatoid/drug therapy ; Arthritis, Rheumatoid/immunology ; Cell Membrane/metabolism ; Immunoglobulins, Intravenous/administration & dosage ; Lectins, C-Type/metabolism ; Mice, Inbred C57BL ; Osteoclasts/metabolism ; Protein Processing, Post-Translational ; Receptors, IgG/metabolism
    Chemical Substances CLEC7A protein, human ; Clec7a protein, mouse ; Fc gamma receptor IIB ; Immunoglobulins, Intravenous ; Lectins, C-Type ; Receptors, IgG
    Language English
    Publishing date 2023-03-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1217235-2
    ISSN 1097-4180 ; 1074-7613
    ISSN (online) 1097-4180
    ISSN 1074-7613
    DOI 10.1016/j.immuni.2023.02.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Clinical testing guidance for histoplasmosis in patients with community-acquired pneumonia for primary and urgent care providers: Role of enzyme immunoassay Histoplasma-specific immunoglobulin G and immunoglobulin M testing.

    Christenson, John C / Barros, Nicolas / Kirkpatrick, Lindsey / Schneider, Jack G

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2024  

    Language English
    Publishing date 2024-01-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciad790
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Association between carriers of the G allele of the + 45T> G variant of the ADIPOQ gene (

    Bruno, Jamila Benvegnú / Dal Ponte, Emanuelle Schneider / Retamoso, Vanessa / Maurer, Patrícia / Berro, Lyana Feijoó / Manfredini, Vanusa / da Costa Escobar Piccoli, Jacqueline

    Heliyon

    2021  Volume 7, Issue 3, Page(s) e06443

    Abstract: Aims: investigate the association between the +45T > G variant of the ADIPOQ gene and ... participated in the study. Lower levels of HDL and adiponectin were observed in patients with G allele and ... association between the +45T > G variant of the ADIPOQ gene and MS risk allele.: Materials and methods ...

    Abstract Aims: investigate the association between the +45T > G variant of the ADIPOQ gene and the metabolic syndrome (MS) in patients with sickle cell trait (SCT). 33 patients with SCT and 35 control group participated in the study. Lower levels of HDL and adiponectin were observed in patients with G allele and sickle cell trait. There were no differences between the prevalence of MS between the groups and there was no association between the +45T > G variant of the ADIPOQ gene and MS risk allele.
    Materials and methods: Participants with and without sickle cell anemia answered a questionnaire, performed anthropometric and laboratory analyzes. They were genotyped for the +45T > G variant of the ADIPOQ gene and evaluated for the presence or absence of metabolic syndrome. The study was approved by the Research Ethics Committee of UNIPAMPA (RS/Brazil).
    Key findings: The GG + TG genetic model, it was associated with lower levels of adiponectin and HDL cholesterol in the SCT group. There was no association between the other studied markers and MS.
    Significance: For the first time, an association was demonstrated between the G allele of the +45T > G variant of the ADIPOQ gene and a worse cardiometabolic profile (lower serum concentrations of adiponectin and HDL cholesterol) in patients with sickle cell trait.
    Language English
    Publishing date 2021-03-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 2835763-2
    ISSN 2405-8440
    ISSN 2405-8440
    DOI 10.1016/j.heliyon.2021.e06443
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Molecular Characterization of the Dual Effect of the GPER Agonist G-1 in Glioblastoma.

    Hirtz, Alex / Bailly, Yann / Rech, Fabien / Pierson, Julien / Dumond, Hélène / Dubois-Pot-Schneider, Hélène

    International journal of molecular sciences

    2022  Volume 23, Issue 22

    Abstract: ... GPER1 (G-protein-coupled estrogen receptor) expression is associated with better survival, especially ... of the GPER agonist G-1 in vivo and characterized its molecular mechanism of action in vitro. First ... the antiproliferative effect of G-1 was confirmed in a model of xenografted nude mice. A transcriptome analysis of GBM ...

    Abstract Glioblastoma (GBM) is the most common primary brain tumor in adults. Despite conventional treatment, consisting of a chirurgical resection followed by concomitant radio-chemotherapy, the 5-year survival rate is less than 5%. Few risk factors are clearly identified, but women are 1.4-fold less affected than men, suggesting that hormone and particularly estrogen signaling could have protective properties. Indeed, a high GPER1 (G-protein-coupled estrogen receptor) expression is associated with better survival, especially in women who produce a greater amount of estrogen. Therefore, we addressed the anti-tumor effect of the GPER agonist G-1 in vivo and characterized its molecular mechanism of action in vitro. First, the antiproliferative effect of G-1 was confirmed in a model of xenografted nude mice. A transcriptome analysis of GBM cells exposed to G-1 was performed, followed by functional analysis of the differentially expressed genes. Lipid and steroid synthesis pathways as well as cell division processes were both affected by G-1, depending on the dose and duration of the treatment. ANGPTL4, the first marker of G-1 exposure in GBM, was identified and validated in primary GBM cells and patient samples. These data strongly support the potential of G-1 as a promising chemotherapeutic compound for the treatment of GBM.
    MeSH term(s) Mice ; Animals ; Female ; Glioblastoma/drug therapy ; Glioblastoma/genetics ; Glioblastoma/metabolism ; Mice, Nude ; Receptors, G-Protein-Coupled/metabolism ; Estrogens/therapeutic use ; Signal Transduction
    Chemical Substances Receptors, G-Protein-Coupled ; Estrogens
    Language English
    Publishing date 2022-11-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms232214309
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Impact of G-CSF Therapy on Leukopenia and Acute Rejection Following Kidney Transplantation.

    Schneider, J / Henningsen, M / Pisarski, P / Walz, G / Jänigen, B

    International journal of organ transplantation medicine

    2021  Volume 12, Issue 2, Page(s) 1–8

    Abstract: ... of rejection and allograft loss. Granulocyte colony-stimulating factor (G-CSF) is used as a therapeutic option ... The goal of this study is to examine the incidence of acute rejections following G-CSF therapy.: Methods ... count in a matched pair analysis.: Results: We identified 12 patients, who received G-CSF therapy ...

    Abstract Background: Leukopenia is a common problem after kidney transplantation. The therapeutic approach typically includes a reduction of the immunosuppressive therapy, which is associated with an increased risk of rejection and allograft loss. Granulocyte colony-stimulating factor (G-CSF) is used as a therapeutic option to raise the leukocyte blood count; however, the effect on acute rejections is controversial.
    Objective: The goal of this study is to examine the incidence of acute rejections following G-CSF therapy.
    Methods: We retrospectively evaluated patients with leukopenia following kidney transplantation and GCSF therapy between January 2007 and December 2017 at our center compared to controls with matched minimal leucocyte blood count in a matched pair analysis.
    Results: We identified 12 patients, who received G-CSF therapy with a cumulative dose of 10.74 µg/kg body weight over a time frame of 4.3 days. G-CSF therapy resulted in a significantly shorter time period with leucocytes <3,000/µL (9.5 vs. 16.6 days), but also trended towards an increased risk of rejection within the next 30 days with three patients in the G-CSF group and no patient in the control group (p=0.06) developing an acute biopsy-proven rejection. Infection and mortality rate in the subsequent year were not different between groups.
    Conclusion: G-CSF therapy decreases the duration of leukopenia post-kidney transplantation, but may also increase the risk of an acute rejection.
    Language English
    Publishing date 2021-07-23
    Publishing country Iran
    Document type Journal Article
    ZDB-ID 2580907-6
    ISSN 2008-6490 ; 2008-6482
    ISSN (online) 2008-6490
    ISSN 2008-6482
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Serotonin G Protein-Coupled Receptor-Based Biosensing Modalities in Yeast.

    Lengger, Bettina / Hoch-Schneider, Emma E / Jensen, Christina N / Jakočiu Nas, Tadas / Petersen, Anja A / Frimurer, Thomas M / Jensen, Emil D / Jensen, Michael K

    ACS sensors

    2022  Volume 7, Issue 5, Page(s) 1323–1335

    Abstract: ... of human pathologies. In humans, serotonin sensing and signaling can occur by 12 G protein-coupled receptors (GPCRs ...

    Abstract Serotonin is a key neurotransmitter involved in numerous physiological processes and serves as an important precursor for manufacturing bioactive indoleamines and alkaloids used in the treatment of human pathologies. In humans, serotonin sensing and signaling can occur by 12 G protein-coupled receptors (GPCRs) coupled to Gα proteins. In yeast, human serotonin GPCRs coupled to Gα proteins have previously been shown to function as whole-cell biosensors of serotonin. However, systematic characterization of serotonin biosensing modalities between variant serotonin GPCRs and application thereof for high-resolution serotonin quantification is still awaiting. To systematically assess GPCR signaling in response to serotonin, we characterized reporter gene expression at two different pHs of a 144-sized library encoding all 12 human serotonin GPCRs in combination with 12 different Gα proteins engineered in yeast. From this screen, we observed changes in the biosensor sensitivities of >4 orders of magnitude. Furthermore, adopting optimal biosensing designs and pH conditions enabled high-resolution high-performance liquid chromatography-validated sensing of serotonin produced in yeast. Lastly, we used the yeast platform to characterize 19 serotonin GPCR polymorphisms found in human populations. While major differences in signaling were observed among the individual polymorphisms when studied in yeast, a cross-comparison of selected variants in mammalian cells showed both similar and disparate results. Taken together, our study highlights serotonin biosensing modalities of relevance to both biotechnological and potential human health applications.
    MeSH term(s) Biosensing Techniques/methods ; Humans ; Receptors, G-Protein-Coupled/genetics ; Receptors, G-Protein-Coupled/metabolism ; Saccharomyces cerevisiae/genetics ; Saccharomyces cerevisiae/metabolism ; Serotonin/analysis ; Signal Transduction
    Chemical Substances Receptors, G-Protein-Coupled ; Serotonin (333DO1RDJY)
    Language English
    Publishing date 2022-04-22
    Publishing country United States
    Document type Journal Article
    ISSN 2379-3694
    ISSN (online) 2379-3694
    DOI 10.1021/acssensors.1c02061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Identification of G protein-coupled receptor 55 (GPR55) as a target of curcumin.

    Harada, Naoki / Okuyama, Mai / Teraoka, Yoshiaki / Arahori, Yumi / Shinmori, Yoh / Horiuchi, Hiroko / Luis, Paula B / Joseph, Akil I / Kitakaze, Tomoya / Matsumura, Shigenobu / Hira, Tohru / Yamamoto, Norio / Iuni, Takashi / Goshima, Naoki / Schneider, Claus / Inui, Hiroshi / Yamaji, Ryoichi

    NPJ science of food

    2022  Volume 6, Issue 1, Page(s) 4

    Abstract: ... us to determine the activation of G protein-coupled receptors (GPCRs) by food components and have identified GPR55 ...

    Abstract The identification of molecular targets of bioactive food components is important to understand the mechanistic aspect of their physiological functions. Here, we have developed a screening system that enables us to determine the activation of G protein-coupled receptors (GPCRs) by food components and have identified GPR55 as a target for curcumin. Curcumin activated GPR55 and induced serum-response element- and serum-response factor-mediated transcription, which were inhibited by Rho kinase and GPR55 antagonists. Both the methoxy group and the heptadienone moiety of curcumin were required for GPR55 activation. The F190
    Language English
    Publishing date 2022-01-14
    Publishing country England
    Document type Journal Article
    ISSN 2396-8370
    ISSN (online) 2396-8370
    DOI 10.1038/s41538-021-00119-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top